Establishing trusting partnerships for successful recruitment of American Indians to clinical trials

Cancer Control

Volumn 15, Issue 3, 2008, Pages 260-268

  Petereit, Daniel G ^a,b,d   Burhansstipanov, Linda ^c  

^a John T Vucurevich Regional Cancer Care Institute   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c Native American Cancer Research   (United States)

^d RAPID CITY REGIONAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN;

AMERICAN INDIAN; ARTICLE; BEHAVIORAL RESEARCH; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RESEARCH; CLINICAL RESEARCH; COMMUNITY HOSPITAL; CONTROLLED STUDY; GENETIC ANALYSIS; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; PROFESSIONAL PRACTICE; PROTEIN ANALYSIS; TREATMENT RESPONSE; TRUST;

EID: 49649123140     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480801500310     Document Type: Article

References (22)

1. Espey DK, Paisano RE, Cobb N. Cancer mortality among American Indians and Alaska Natives: regional difference, 1994-1998. Rockville, MD: Indian Health Service; October 2003.
2. Petereit DG, Rogers D, Govern F, et al. Increasing access to clinical cancer trials and emerging technologies for minority populations: the Native American Project. J Clin Oncol. 2004;22(22):4452-4455.
3. Petereit DG, Rogers D, Burhansstipanov L, et al. Walking Forward: the South Dakota Native American Project. J Cancer Educ. 2005;20(suppl 1):65-70.
4. Rogers D, Petereit DG. Cancer disparities research partnership in Lakota Country: clinical trials, patient services and community education for the Oglala, Rosebud and Cheyenne River Sioux tribes. Am J Public Health. 2005;95(12):2129-2132.
5. Burhansstipanov L, Bemis LT, Petereit DG. Native American communities perspective and genetics. In: Monsen R, ed. Genetics and Ethics in Health Care: New Questions in the Age of Genomic Health. Silver Spring, MD: American Nurses Publishing; 2008. In press.
6. Christopher S. Recommendations for conducting successful research with Native Americans. J Cancer Educ. 2005;20(1 suppl):47-51.
7. Burhansstipanov L, Christopher S, Schumacher SA. Lessons learned from community-based participatory research in Indian Country. Cancer Control. 2005;12(supp2):70-76.
8. Human Genome Project Information: Minorities, Race, and Genomics. US Dept of Energy Office of Science, Office of Biological and Environmental Research, Human Genome Program, 2006. http://www.ornl.gov/sci/techresources/Human_Genome/ elsi/minorities.shtml. Accessed on April 16, 2008.
9. Human Genome Diversity Project: Model Ethical Protocol for Collecting DNA Samples. North American Regional Committee: Morrison Institute for Population and Resource Studies, Stanford University, 1999. http://www.stanford.edu/group/ morrinst/hgdp/protocol.html#Q1. Accessed on April 16, 2008.
10. Burhansstipanov L, Bemis L, Kaur JS, et al. Sample genetic policy language for research conducted with Native communities. J Cancer Educ. 2005;20(suppl 1):52-57.
11. Mackie TR, Kapatoes J, Ruchala K, et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2003;56(1):89-105.
12. Eastmo E, Petereit DG. Accelerated partial breast irradiation: expanding options for breast preservation. Adv Imaging Oncol Admin. 2005:91-95.
13. Tucker SL, Turesson L, Thames HD. Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer. 1992;28(A):1783-1791.
14. Russell NS, Knaken H, Bruinvis IA, et al. Quantification of patient to patient variation of skin erythema developing as a response to radiotherapy. Radiother Oncol. 1994;30(3):213-221.
15. Geara FB, Peters LJ, Ang KK, et al. Intrinsic radiosensitivity of normal human fibroblasts and lymphocytes after high- and low-dose-rate irradiation. Cancer Res. 1992;52(22):6348-6352.
16. Weichselbaum RR, Epstein J, Little JB. In vitro radiosensitivity of human diploid fibroblasts derived from patients with unusual clinical responses to radiation. Radiology. 1976;121(2):479-482.
17. Swift M, Morrell D, Massey RB, et al. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med. 1991;325(26):1831-1836.
18. Iannuzzi CM, Atencio DP, Green S, et al. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys. 2002;52(3):606-613.
19. Molloy K, Reiner M, Ratteree K, et al. Cultural competency in cancer care: developing and implementing a patient navigator program in American Indian communities. Assoc Community Cancer Cent. 2007;22(5).
20. Petereit DG, Molloy K, Reiner ML, et al. Establishing a patient navigator program to reduce cancer disparities in the American Indian communities of western South Dakota: initial observations and results. Cancer Control. 2008;15(3):254-259.
21. Svensson JP, Stalpers LJ, Esveldt-van Lange RE, et al. Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med. 2006;3(10):e422.
22. Claudino WM, Quattrone A, Biganzoli L, et al. Metabolomics: available results, current research projects in breast cancer, and future applications. J Clin Oncol. 2007;25(19):2840-2846. Epub 2007 May 14.